美国 · SEC FORM 4
Veradermics, Inc
MANE · NYSE · CIK 0001827635 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
20 同一窗口内观察到的 Form 4 交易行
15 sales · 5 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
—
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-02-06 · Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; SUVRETTA CAPITAL MANAGEMENT, LLC.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 4,244,476
- 上期报告
- 4,106,974
- 日均成交量
- 907,033
- 回补天数
- 4.7
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-02-06 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; SUVRETTA CAPITAL MANAGEMENT, LLC | 买入 (P) | Common stock, par value $0.00001 per share | 30,521 | USD 36.34 | USD 1,109,056 | SEC 申报 ↗ |
| 2026-02-05 | CHILDS JOHN W | 买入 (P) | Common Stock | 294,117 | USD 17.00 | USD 4,999,989 | SEC 申报 ↗ |
| 2026-02-05 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; SUVRETTA CAPITAL MANAGEMENT, LLC | 买入 (P) | Common stock, par value $0.00001 per share | 96,200 | USD 37.99 | USD 3,655,079 | SEC 申报 ↗ |
| 2026-02-05 | Longitude 103.8 East Partners, LLC; Longitude 103.8 East, L.P.; Longitude Capital Partners V, LLC; Longitude Venture Partners V, L.P. | 买入 (P) | Common Stock | 1,075,000 | USD 17.00 | USD 18,275,000 | SEC 申报 ↗ |
| 2026-02-05 | ENRIGHT PATRICK G | 买入 (P) | Common Stock | 1,075,000 | USD 17.00 | USD 18,275,000 | SEC 申报 ↗ |
| 2026-02-05 | Coric Vlad | 买入 (P) | Common Stock | 58,823 | USD 17.00 | USD 999,991 | SEC 申报 ↗ |
| 2026-02-05 | CHILDS JOHN W | 买入 (P) | Common Stock | 294,117 | USD 17.00 | USD 4,999,989 | SEC 申报 ↗ |
| 2026-02-04 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; SUVRETTA CAPITAL MANAGEMENT, LLC | 买入 (P) | Common stock, par value $0.00001 per share | 155,953 | USD 37.05 | USD 5,778,342 | SEC 申报 ↗ |
Form 4 申报证据
60 transaction lines in the latest 365-day window; 60 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Hollander David | 奖励/授予 (A) | Common Stock | 9,650 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-20 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; MONTANOVA CAPITAL, LLC | X (X) | Common stock, par value $0.00001 per share | 300,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-19 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; MONTANOVA CAPITAL, LLC | 卖出 (S) | Common stock, par value $0.00001 per share | 750,000 | USD 107.25 | USD 80,437,500 | SEC 申报 ↗ |
展开近期 Form 4 证据 (23 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Hollander David | 奖励/授予 (A) | Common Stock | 9,650 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-20 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; MONTANOVA CAPITAL, LLC | X (X) | Common stock, par value $0.00001 per share | 300,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-19 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; MONTANOVA CAPITAL, LLC | 卖出 (S) | Common stock, par value $0.00001 per share | 750,000 | USD 107.25 | USD 80,437,500 | SEC 申报 ↗ |
| 2026-08-17 | Waldman Reid Alexander | 卖出 (S) | Common Stock | 67,500 | USD 107.86 | USD 7,280,713 | SEC 申报 ↗ |
| 2026-08-17 | Waldman Reid Alexander | 期权行权/转换 (M) | Common Stock | 3,452 | USD 12.19 | USD 42,080 | SEC 申报 ↗ |
| 2026-08-17 | Durso Timothy August | 卖出 (S) | Common Stock | 43,500 | USD 107.82 | USD 4,690,005 | SEC 申报 ↗ |
| 2026-08-17 | Durso Timothy August | 期权行权/转换 (M) | Common Stock | 3,452 | USD 12.19 | USD 42,080 | SEC 申报 ↗ |
| 2026-08-12 | CHILDS JOHN W | 卖出 (S) | Common Stock | 100,000 | USD 107.12 | USD 10,711,700 | SEC 申报 ↗ |
| 2026-02-06 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; SUVRETTA CAPITAL MANAGEMENT, LLC | 买入 (P) | Common stock, par value $0.00001 per share | 30,521 | USD 36.34 | USD 1,109,056 | SEC 申报 ↗ |
| 2026-02-05 | CHILDS JOHN W | 买入 (P) | Common Stock | 294,117 | USD 17.00 | USD 4,999,989 | SEC 申报 ↗ |
| 2026-02-05 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; SUVRETTA CAPITAL MANAGEMENT, LLC | 买入 (P) | Common stock, par value $0.00001 per share | 96,200 | USD 37.99 | USD 3,655,079 | SEC 申报 ↗ |
| 2026-02-05 | Waldman Reid Alexander | C (C) | Common Stock | 1,437 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-05 | Longitude 103.8 East Partners, LLC; Longitude 103.8 East, L.P.; Longitude Capital Partners V, LLC; Longitude Venture Partners V, L.P. | 买入 (P) | Common Stock | 1,075,000 | USD 17.00 | USD 18,275,000 | SEC 申报 ↗ |
| 2026-02-05 | Longitude 103.8 East Partners, LLC; Longitude 103.8 East, L.P.; Longitude Capital Partners V, LLC; Longitude Venture Partners V, L.P. | C (C) | Common Stock | 2,407,752 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-05 | Grant-Kels Jane M. | C (C) | Common Stock | 2,455 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-05 | ENRIGHT PATRICK G | 买入 (P) | Common Stock | 1,075,000 | USD 17.00 | USD 18,275,000 | SEC 申报 ↗ |
| 2026-02-05 | ENRIGHT PATRICK G | C (C) | Common Stock | 2,407,752 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-05 | Durso Timothy August | C (C) | Common Stock | 1,473 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-05 | Coric Vlad | 买入 (P) | Common Stock | 58,823 | USD 17.00 | USD 999,991 | SEC 申报 ↗ |
| 2026-02-05 | Coric Vlad | C (C) | Common Stock | 377,687 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-05 | CHILDS JOHN W | 买入 (P) | Common Stock | 294,117 | USD 17.00 | USD 4,999,989 | SEC 申报 ↗ |
| 2026-02-05 | CHILDS JOHN W | C (C) | Common Stock | 1,907,889 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-04 | Averill Madison Master Fund, Ltd.; Averill Master Fund, Ltd.; Cowen Aaron; SUVRETTA CAPITAL MANAGEMENT, LLC | 买入 (P) | Common stock, par value $0.00001 per share | 155,953 | USD 37.05 | USD 5,778,342 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | MANE |
| CIK | 0001827635 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 60 transaction lines from 2026-02-04 to 2026-09-01 26 P purchase lines · 15 S sale lines · 19 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.